Published in Virology on February 01, 2001
Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol (2002) 1.87
Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol (2004) 1.85
A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. J Gen Virol (2010) 1.49
Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression. J Virol (2001) 1.29
Pangaea and the Out-of-Africa Model of Varicella-Zoster Virus Evolution and Phylogeography. J Virol (2012) 1.17
Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination. J Virol (2011) 1.16
New variant of varicella-zoster virus. Emerg Infect Dis (2002) 1.15
Complete DNA sequences of two oka strain varicella-zoster virus genomes. J Virol (2008) 1.06
Genotyping of clinical varicella-zoster virus isolates collected in China. J Clin Microbiol (2009) 1.05
Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J Clin Microbiol (2006) 1.01
Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax. Virol J (2011) 0.97
The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation. J Virol (2012) 0.95
Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes. Infect Genet Evol (2012) 0.92
Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D. J Clin Microbiol (2007) 0.88
Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo. J Virol (2005) 0.85
Genetic analysis of clinical VZV isolates collected in China reveals a more homologous profile. Biomed Res Int (2013) 0.81
Coinfection with two closely related alphaherpesviruses results in a highly diversified recombination mosaic displaying negative genetic interference. J Virol (2009) 0.81
Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet. Med Microbiol Immunol (2011) 0.77
Analysis of enzymatic digestion pattern of two open reading frames of Varciella-Zoster genome from Kuwaiti patients using the RFLP technique. Iran J Microbiol (2012) 0.75
Genotyping of clinical varicella-zoster virus isolates collected from Yunnan in Southwestern China. Biomed Rep (2015) 0.75
Enzymatic Digestion Pattern of Varicella Zoster Virus ORF38 and ORF54 in Chickenpox Patients Using RFLP Technique. Iran J Pathol (2016) 0.75
Nationwide distribution of varicella-zoster virus clades in China. BMC Infect Dis (2016) 0.75
Genetic analysis of varicella-zoster virus in the aqueous humor in uveitis with severe hyphema. BMC Infect Dis (2017) 0.75
Characterization and phylogenetic analysis of Varicella-zoster virus strains isolated from Korean patients. J Microbiol (2017) 0.75
Rapid identification of Mycobacterium avium complex in culture using DNA probes. J Clin Microbiol (1987) 10.75
Techniques for the recovery and identification of Cryptosporidium oocysts from stool specimens. J Clin Microbiol (1983) 6.16
A comparison of the formalin-ether concentration and trichrome-stained smear methods for the recovery and identification of intestinal protozoa. Am J Med Technol (1979) 3.91
Fluorescence detection of Cryptosporidium oocysts in human fecal specimens by using monoclonal antibodies. J Clin Microbiol (1987) 3.15
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Ann Intern Med (1991) 2.41
Partner's influence on patient preference for treatment in early prostate cancer. BJU Int (2003) 2.33
Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment. J Virol (1988) 2.22
Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect Immun (1978) 2.15
Evaluation of a new monoclonal antibody combination reagent for direct fluorescence detection of Giardia cysts and Cryptosporidium oocysts in human fecal specimens. J Clin Microbiol (1992) 2.14
Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J Virol (1997) 2.14
Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J Virol (1985) 2.09
Effects of Magnesium on Intact Chloroplasts: I. EVIDENCE FOR ACTIVATION OF (SODIUM) POTASSIUM/PROTON EXCHANGE ACROSS THE CHLOROPLAST ENVELOPE. Plant Physiol (1980) 2.06
Microbial contamination of contact lens care systems. Am J Ophthalmol (1987) 2.03
Primary Epstein-Barr-virus infections in acute neurologic diseases. N Engl J Med (1975) 2.02
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology (2000) 1.99
Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol (1994) 1.99
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun (1983) 1.95
Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J Virol (1995) 1.89
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol (1992) 1.81
Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. Am J Ophthalmol (2001) 1.76
The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology (1980) 1.72
Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology (1995) 1.72
Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics (1981) 1.69
Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol (1979) 1.64
Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J Virol (1998) 1.62
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59
Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system. J Virol (1993) 1.58
Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. Proc Natl Acad Sci U S A (1989) 1.56
New biphasic culture system for isolation of mycobacteria from blood of patients with acquired immune deficiency syndrome. J Clin Microbiol (1984) 1.56
Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J (1990) 1.53
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol (2001) 1.53
Evaluation of intestinal parasite morphology in polyvinyl alcohol preservative: comparison of copper sulfate and mercuric chloride bases for use in Schaudinn fixative. J Clin Microbiol (1983) 1.52
Enzyme-linked immunoabsorbent assays in the detection of Chlamydia trachomatis: how valid are they? Diagn Microbiol Infect Dis (1988) 1.52
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology (1984) 1.49
Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction. PCR Methods Appl (1992) 1.49
Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. Antimicrob Agents Chemother (1981) 1.49
Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol (1996) 1.49
Evaluation of intestinal protozoan morphology in polyvinyl alcohol preservative: comparison of zinc sulfate- and mercuric chloride-based compounds for use in Schaudinn's fixative. J Clin Microbiol (1993) 1.49
Serine protein kinase associated with varicella-zoster virus ORF 47. Virology (1992) 1.48
Reliability of two novel methods, Alamar and E test, for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1993) 1.48
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J Virol (1990) 1.46
Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology (1994) 1.46
Pyomyositis in an adolescent female athlete. J Pediatr Surg (1995) 1.43
Acute fever and petechial rash associated with influenza A virus infection. Clin Infect Dis (1999) 1.41
Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis (1979) 1.40
Identification of the phosphorylation sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. J Virol (1993) 1.40
Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients. Clin Infect Dis (1998) 1.39
Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology (2006) 1.39
Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles. J Infect Dis (1983) 1.39
Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol (2001) 1.37
Practical strategies for detecting and confirming vancomycin-intermediate Staphylococcus aureus: a tertiary-care hospital laboratory's experience. J Clin Microbiol (2001) 1.37
Entry and egress of varicella virus blocked by same anti-gH monoclonal antibody. Virology (1993) 1.36
Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain. Virology (1998) 1.35
Replication of HIV-1 in primary monocyte cultures. Virology (1990) 1.32
Comparative in vitro activity of the new macrolide A-56268 against mycobacteria. Eur J Clin Microbiol (1987) 1.32
In vitro activity of HR 810, a new cephalosporin. Antimicrob Agents Chemother (1984) 1.32
Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression. J Virol (2001) 1.29
Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor. Virology (1990) 1.29
Clinical comparison of the AutoMicrobic system gram-positive identification card, API Staph-Ident, and conventional methods in the identification of coagulase-negative Staphylococcus spp. J Clin Microbiol (1983) 1.28
Interactions among structural proteins of varicella zoster virus. Arch Virol Suppl (2001) 1.27
Comparison of API Rapid Strep, Baxter MicroScan Rapid Pos ID Panel, BBL Minitek Differential Identification System, IDS RapID STR System, and Vitek GPI to conventional biochemical tests for identification of viridans streptococci. Am J Clin Pathol (1991) 1.26
Comparison of Enteric-Tek with API 20E and conventional methods for identification of Enterobacteriaceae. J Clin Microbiol (1982) 1.24
Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology (1986) 1.23
In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis. J Antimicrob Chemother (1987) 1.23
Mycobacterium avium: a pathogen of patients with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis (1984) 1.20
Chaperone functions common to nonhomologous Epstein-Barr virus gL and Varicella-Zoster virus gL proteins. J Virol (1997) 1.18
Varicella zoster virus glycoprotein gpI is selectively phosphorylated by a virus-induced protein kinase. Proc Natl Acad Sci U S A (1986) 1.18
Comparison of rapid identification method and conventional substrates for identification of Corynebacterium group JK isolates. J Clin Microbiol (1987) 1.18
Multicenter evaluation of the MicroScan Rapid Gram-Negative Identification Type 3 Panel. J Clin Microbiol (1997) 1.17
Bell's palsy and infectious mononucleosis. Lancet (1973) 1.17
Comparison of indirect fluorescent-antibody amoebic serology with counterimmunoelectrophoresis and indirect hemagglutination amoebic serologies. J Clin Microbiol (1982) 1.15
Immunity to varicella-zoster viral glycoproteins, gp I (gp 90/58) and gp III (gp 118), and to a nonglycosylated protein, p 170. J Immunol (1986) 1.15
Differential expression in human and mouse cells of human immunodeficiency virus pseudotyped by murine retroviruses. J Virol (1990) 1.15
Critical evaluation of 4-week incubation for fungal cultures: is the fourth week useful? J Clin Microbiol (1998) 1.14
Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J Virol (1999) 1.13
Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation. J Infect Dis (1984) 1.13
Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex). J Virol (1994) 1.13
Detection of microsporidial spores in fecal specimens from patients diagnosed with cryptosporidiosis. J Clin Microbiol (1994) 1.12
Comparative evaluation of the Eiken and API 20E systems and conventional methods for identification of members of the family Enterobacteriaceae. J Clin Microbiol (1984) 1.12
Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140). J Virol (1987) 1.07
Application of PCR to multiple specimen types for diagnosis of cytomegalovirus infection: comparison with cell culture and shell vial assay. J Clin Microbiol (1994) 1.05
Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay. Infect Control Hosp Epidemiol (2001) 1.04
Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and by a microbroth method. Rev Infect Dis (1984) 1.03
Human leukocytes kill varicella-zoster virus-infected fibroblasts in the presence of murine monoclonal antibodies to virus-specific glycoproteins. J Virol (1985) 1.03
Epstein-Barr virus and Guillain-Barré syndrome. Lancet (1972) 1.03
Herpesvirus antibody levels in the etiologic diagnosis of the acute retinal necrosis syndrome. Am J Ophthalmol (1992) 1.02
Sinus tract extension of a liver hydatid cyst and recovery of diagnostic hooklets in sputum. Am J Clin Pathol (1986) 1.02
Cryopreservation of varicella-zoster virions without loss of structural integrity or infectivity. Intervirology (1981) 1.02
Immunoprecipitable polypeptides specified by varicella-zoster virus. Virology (1982) 1.01
Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis (2000) 1.00
Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Am J Med (1990) 1.00
Varicella-zoster virus p32/p36 complex is present in both the viral capsid and the nuclear matrix of the infected cell. J Virol (1986) 1.00
Immunogenic glycoproteins of laboratory and vaccine strains of Varicella-Zoster virus. Infect Immun (1981) 0.99
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. Am J Ophthalmol (1993) 0.98
Clinical evaluation of three rapid methods for the detection of significant bacteriuria. J Clin Microbiol (1985) 0.98
Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects. J Infect Dis (1989) 0.98
Aseptic meningitis in an infant with rotavirus gastroenteritis. Pediatr Infect Dis (1984) 0.97
Purification and molecular anatomy of the varicella-zoster virion. Biken J (1983) 0.96